Log In
BCIQ
Print this Print this
 

TGFK09SD

  Manage Alerts
Collapse Summary General Information
Company Fabre-Kramer Pharmaceuticals Inc.
DescriptionSerotonin (5-HT1A) receptor agonist
Molecular Target Serotonin (5-HT1A) receptor
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationSexual dysfunction
Indication DetailsTreat hypoactive sexual desire disorder (HSDD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today